☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
amends
Moderna Amends its Agreement with UK Government for an Additional 2M Doses of COVID-19 Vaccine
November 30, 2020
Eli Lilly Amends its 2013 Agreement with Chi-Med to Commercialize Elunate (fruquintinib) in China
July 28, 2020
Thermo Fisher Scientific Amends its Agreement to Acquire QIAGEN
July 17, 2020
Sierra Oncology Amends its Asset Purchase Agreement with Gilead for Momelotinib Signed in 2018
November 8, 2019
AstraZeneca Amends its Development and Commercialization Agreement with Ironwood for Linzess (linaclotide) Signed in 2012
September 18, 2019
GSK Amends its Development and Commercialization Agreement with Liquidia for Inhaled Therapies
June 27, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.